Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: A retrospective study of physician-patient pairs in Taiwan-Reference-Cited by-同舟云学术

Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: A retrospective study of physician-patient pairs in Taiwan

Published:2009-11 Issue:11 Volume:31 Page:2618-2627
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Hsiao Fei-Yuan,Tsai Yi-Wen,Huang Weng-Foung

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference25 articles.

1. The coxibs, selective inhibitors of cyclooxygennase-2;Fitz Gerald;N Engl J Med.,2001

2. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?;Barozzi;Pharmacoepidemiol Drug Saf.,2007

3. Review article: Recommendations for the clinical management of patients taking non-steroidal anti-inflammatory drugs—a gastroenterologist's prospective;Lanas;Aliment Pharmacol Ther.,2005

4. NSAID-induced gastrointestinal damage: Current clinical management and recommendations for prevention;Lanas;Chin J Dig Dis.,2006

5. National trends in cyclooxygenase-2 inhibitor use since market release: Non-selective diffusion of a selectively cost-effective innovation;Dai;Arch Intern Med.,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyridazine derivatives as selective COX‐2 inhibitors: A review on recent updates;Drug Development Research;2023-09-26

2. Anti‐inflammatory activity of pyridazinones: A review;Archiv der Pharmazie;2022-05-09

3. Antiinflammatory Properties of Schinus terebinthifolius and Its Use in Arthritic Conditions;Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases;2019

4. Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients;European Journal of Clinical Pharmacology;2017-09-02

5. Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database;Drug Safety;2017-06-29